Reptilase® Clotting Time
Reptilase® is an enzyme derived from the venom of Bothrops atrox or Bothrops jararaca, South American pit vipers. Reptilase cleaves a fibrinopeptide from fibrinogen directly, bypassing the heparin-antithrombin system, and produces a fibrin clot. The principle of reptilase is it hydrolyzes fibrinopeptide A from intact fibrinogen, whereas thrombin hydrolyzes fibrinopeptide A and B from fibrinogen. The clot that forms from reptilase is more fragile than from thrombin. The reptilase time will be normal in heparin toxicity, even when the thrombin time is infinite. The replilase time (RT) is also unaffected by hirudin and other antithrombins, and will remain normal in their presence. When the thrombin time is prolonged, the reptilase time is useful in distinguishing the presence of an antithrombin (normal reptilase time) from hypofibrinogenemia or dysfibrinogenemia (prolonged reptilase time). Dysfibrinogenemia is a rare hereditary or acquired condition characterized by dysfunctional fibrinogen. Inherited dysfibrinogenemia can cause bleeding, thrombosis, or both. Most patients with hereditary dysfibrinogenemia are heterozygous with mild symptoms and bleeding. Acquired dysfibrinogenemia can have similar symptoms and it is characterized by bleeding and thrombosis. Causes of acquired dysfibrinogenemia include liver disease, hepatoma, and increased synthesis of fibrinogen. The reptilase time is only slightly prolonged by fibrin degradation products. If the reptilase time is abnormal, additional testing of a 1:1 plasma mix can be performed to further evaluate for hypofibrinogenemia or dysfibrinogenemia.
- Evaluation of a prolonged thrombin time
- Diagnosis of inherited and acquired dysfibrinogenemia
- As an aid in diagnosis of thrombotic and bleeding disorders due to fibrinogen abnormalities such as in liver disease and hepatomas
- Evaluate for the presence of heparin in the specimen
Increased in:
- Hereditary decreased or abnormal fibrinogen such as hypofibrinogenemia, dysfibrinogenemia, afibrinogenemia
- Liver disease
- Disseminated intravascular coagulation (DIC)
- Paraproteinemia
- Other conditions with elevated fibrin degradation products including thrombotic thrombocytopenic purpura, thrombosis, pulmonary embolus, hemolytic uremic syndrome, recent surgery
Approximately 18-22 sec
Plasma Citrate (Light Blue).
Freeze immediately and maintain frozen until tested.
Stability
- Ambient: Unacceptable
- Refrigerated: Unacceptable
- Frozen: 14 days
- Arch Pathol Lab Med. 2002;126:499. [PMID: 11900586]
- Haemophilia. 2008 Sep;14(5):889-97. [PMID: 18564189]
- Am J Hematol. 2008 Dec;83(12):928-31. [PMID: 18951466]
- Jacobs DS, DeMott WR. Laboratory Test Handbook. 5th. Hudson, OH Lexi-Comp, Inc (2001).